282 related articles for article (PubMed ID: 34510141)
1. Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.
Vela J; Dreyer L; Petersen KK; Arendt-Nielsen L; Duch KS; Kristensen S
Pain; 2022 Jun; 163(6):1206-1214. PubMed ID: 34510141
[TBL] [Abstract][Full Text] [Related]
2. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
Johnson JR; Burnell-Nugent M; Lossignol D; Ganae-Motan ED; Potts R; Fallon MT
J Pain Symptom Manage; 2010 Feb; 39(2):167-79. PubMed ID: 19896326
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S
J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178
[TBL] [Abstract][Full Text] [Related]
5. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
6. Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
Pramhas S; Thalhammer T; Terner S; Pickelsberger D; Gleiss A; Sator S; Kress HG
Lancet Reg Health Eur; 2023 Dec; 35():100777. PubMed ID: 38033459
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.
Serpell M; Ratcliffe S; Hovorka J; Schofield M; Taylor L; Lauder H; Ehler E
Eur J Pain; 2014 Aug; 18(7):999-1012. PubMed ID: 24420962
[TBL] [Abstract][Full Text] [Related]
8. An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis.
Bawa Z; Lewis D; Gavin PD; Libinaki R; Joubran L; El-Tamimy M; Taylor G; Meltzer R; Bedoya-Pérez M; Kevin RC; McGregor IS
Sci Rep; 2024 May; 14(1):11792. PubMed ID: 38783008
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
10. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
[TBL] [Abstract][Full Text] [Related]
11. The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain.
Bebee B; Taylor DM; Bourke E; Pollack K; Foster L; Ching M; Wong A
Med J Aust; 2021 May; 214(8):370-375. PubMed ID: 33846971
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol as an Alternative Analgesic for Acute Dental Pain.
Chrepa V; Villasenor S; Mauney A; Kotsakis G; Macpherson L
J Dent Res; 2024 Mar; 103(3):235-242. PubMed ID: 37910667
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.
Verrico CD; Wesson S; Konduri V; Hofferek CJ; Vazquez-Perez J; Blair E; Dunner K; Salimpour P; Decker WK; Halpert MM
Pain; 2020 Sep; 161(9):2191-2202. PubMed ID: 32345916
[TBL] [Abstract][Full Text] [Related]
14. Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.
Rog DJ; Nurmikko TJ; Young CA
Clin Ther; 2007 Sep; 29(9):2068-79. PubMed ID: 18035205
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.
Wenham CY; Hensor EM; Grainger AJ; Hodgson R; Balamoody S; Doré CJ; Emery P; Conaghan PG
Rheumatology (Oxford); 2012 Dec; 51(12):2286-94. PubMed ID: 22956551
[TBL] [Abstract][Full Text] [Related]
16. Quantitative sensory testing, psychological profiles and clinical pain in patients with psoriatic arthritis and hand osteoarthritis experiencing pain of at least moderate intensity.
Vela J; Dreyer L; Petersen KK; Arendt-Nielsen L; Duch KS; Amris K; Kristensen S
Eur J Pain; 2024 Feb; 28(2):310-321. PubMed ID: 37712295
[TBL] [Abstract][Full Text] [Related]
17. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Grimison P; Mersiades A; Kirby A; Lintzeris N; Morton R; Haber P; Olver I; Walsh A; McGregor I; Cheung Y; Tognela A; Hahn C; Briscoe K; Aghmesheh M; Fox P; Abdi E; Clarke S; Della-Fiorentina S; Shannon J; Gedye C; Begbie S; Simes J; Stockler M
Ann Oncol; 2020 Nov; 31(11):1553-1560. PubMed ID: 32801017
[TBL] [Abstract][Full Text] [Related]
18. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial.
van der Flier FE; Kwee CMB; Cath DC; Batelaan NM; Groenink L; Duits P; van der Veen DC; van Balkom AJLM; Baas JMP
BMC Psychiatry; 2019 Feb; 19(1):69. PubMed ID: 30760241
[TBL] [Abstract][Full Text] [Related]
20. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
Vorsanger G; Xiang J; Jordan D; Farrell J
Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
